Therefore, the purpose of our study was to further investigate the relationships among circulating galectin-3 and adiponectin on type 2 diabetes in a community population of different age groups and whether their joint action plays an outstanding role in diabetes risk assessment. Here, ADIPOQ is linked to type 2 diabetes mellitus.